Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt

Author：            

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.1, 2014-01, pp. : 183-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 348-353

Karger

Access to resources Recommend Favorite

3,3'-Diindolylmethane suppresses growth of human esophageal squamous cancer cells by G1 cell cycle arrest

By      

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1669-1673

Spandidos Publications

Access to resources Recommend Favorite

Pterostilbene Inhibits the Growth of Human Esophageal Cancer Cells by Regulating Endoplasmic Reticulum Stress

By  

Cellular Physiology and Biochemistry, Vol. 38, Iss. 3, 2016-03 ,pp. : 1226-1244

Karger

Access to resources Recommend Favorite

p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway

By          

International Journal of Oncology, Vol. 44, Iss. 6, 2014-01 ,pp. : 2153-2159

Spandidos Publications

Access to resources Recommend Favorite

Diallyl disulfide inhibits growth and metastatic potential of human triple‐negative breast cancer cells through inactivation of the β‐catenin signaling pathway

By  

MOLECULAR NUTRITION & FOOD RESEARCH, Vol. 59, Iss. 6, 2015-06 ,pp. : 1063-1075

John Wiley & Sons Inc

Access to resources Recommend Favorite